Likewise, our data showed HER2low TNBC actively participated in activities with regard to tumor metabolism and growth pathways with MUCL1, PTN, SCGB2A2 and APOD highly expressed, revealing an increased metabolic and proliferative capacity contained. The gene discussed is SCGB2A2; the disease is neoplasm.